Compound class:
Synthetic organic
Comment: Example 36 is one of a number of leukotriene C4 synthase (LTC4S) inhibitors claimed in AstraZeneca patent WO2016177845 [2], particularly for the treatment of respiratory diseases and inflammation. In support of this enzyme as a drug target, a paper by Kleinschmidt et al. (2015) [1] demonstrates that LTC4S inhibitors block leukotriene C4 and cys-LT synthesis in vitro and in vivo, but note that their inhibitors are of quite different structure compared to example 36.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
2-[5-[cyclopropylmethyl(1,2-dihydroacenaphthylen-5-yl)amino]-3-methoxypyridine-2-carbonyl]cyclopropane-1-carboxylic acid |
Database Links | |
GtoPdb PubChem SID | 336446941 |
PubChem CID | 122670075 |
Search Google for chemical match using the InChIKey | FQHWQFIPEVBFKT-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | FQHWQFIPEVBFKT |
UniChem Compound Search for chemical match using the InChIKey | FQHWQFIPEVBFKT-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FQHWQFIPEVBFKT-UHFFFAOYSA-N |